Tag: PCR LV 2018
Olaf Wendler
Olaf Wendler (lead for Cardiothoracic Surgery, King’s Health Partners, and chair of the Heart and ...
PCR LV 2018: One-year results of VIVA confirm safety and efficacy of valve-in-valve procedures with CoreValve
Speaking at PCR London Valves (9–11 September, London, UK) Didier Tchétché (Clinique Pasteur, Toulou...
PCR LV 2018: Early discharge feasible for unselected TAVI patients
Data from the multicentre FAST-TAVI trial indicate that early discharge—discharge within 72 hour...
PCR LV 2018: Favourable outcomes for next-generation Acurate neo2 TAVI system
A new study evaluating the safety and performance of the Acurate neo2 (Boston Scientific) transc...
